Loading the company…
Loading the company…
㈜뉴라이프비에스티
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-10-11 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Seoul, founded in 2021. Industry: R&D & Professional Services. Revenue for 2025 was ₩2.1bn. It has 8 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2024-04-17 · latest registration 2026-03-03 · newest first
본 발명은 움벨리페론(Umbelliferone)을 유효성분으로 포함하는 피부 미백용 화장료 조성물; 및 이에 스코폴레틴을 추가로 포함하는 화장료 조성물에 관한 것이다. 보다 구체적으로, 본 발명의 움벨리페론 및 스코폴레틴을 포함하는 조성물은 피부미백에 시너지 효과를 가지므로 화장료 조성물, 의약외품 조성물로서 유용하게 사용될 수 있다. 본 발명은 움벨리페론; 및 스코폴레틴을 유효성분으로 포함하는 피부 미백용 화장료 조성물에 관한 것으로 멜라닌 생성량 감소, 멜라닌 생합성 억제, MITF 전사인자 감소, 티로시나제 활성 감소 및 mRNA 발현 감소를 통해 피부 미백에 뛰어난 효능을 제공한다.
본 발명은 역미셀을 형성하는 발효유화제를 이용하여 항산화 효능물질을 포집시킨 조성물에 관한 것으로, 활성물질을 피부에 효율적으로 통과시켜 지질층에 효과적으로 전달할 수 있다. 또한, 용해성, 유화성, 산화 안정성, 활성물질의 효능 등을 향상시킬 수 있으며, 합성물이 아닌 발효물로써 친환경적이고, 피부세포에 대한 독성이 없어 인체 친화적이므로 다양한 분야에 용이하게 적용할 수 있다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 2 of 2 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 2.3 | 2.1 |
| Cost of sales | 0.0 | 0.2 |
| Gross profit (loss) | 2.3 | 1.9 |
| Selling, general and administrative expenses | 2.1 | 1.9 |
| Operating income (loss) | 0.1 | (0.0) |
| Non-operating income | 1.5 | 1.6 |
| Other gains | 0.0 | 0.0 |
| Finance income | 1.5 | 1.6 |
| Other | 0.0 | 0.0 |
| Non-operating expenses | 2.1 | 9.6 |
| Other losses | 0.0 | — |
| Finance costs | 0.3 | 0.4 |
| Other | 1.8 | 9.2 |
| Profit (loss) before tax | (0.5) | (8.1) |
| Income tax expense | 0.3 | 0.4 |
| Net income (loss) | (0.8) | (8.5) |
Revenue ₩2.1bn, down 9.3% YoY.
Operating margin -0.7% (prior 6.3%).
Net income ₩-8.5bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.